Improving Treatment of Advanced Breast Cancer ECHO
May 2025 - November 2025
Rapid innovation in advanced breast cancer leads to complex shared decision-making for interdisciplinary oncology teams. The American Cancer Society has developed an ECHO program with the goal to address best practices in shared decision-making and high-quality treatment of advanced breast cancer. The target audience is interdisciplinary clinical care teams (clinicians, physicians, nurses, navigators, social workers etc.) This program will be offering NO-COST Continuing Medical Education (CME, CE, CEU) and Continuing Nursing Education (CNE) credits.
The Improving Treatment of Advanced Breast Cancer ECHO is supported by Gilead who provided funding. Gilead has had no input into the content of the materials used.